Recursion Pharmaceuticals Overview
Recursion Pharmaceuticals Target Price
Analysts' 12-month price predictions for RXRX.
Get informed when a big investor buys or sells
+ FollowShare Price
$3.8
Average Target Price
$5.50
44.7% upside
44.7% upside1 analysts in the last 4 months
High: $5.5 | Low: $5.5
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-14 | Morgan Stanley | $5.5 | 44.7% upside |  |
| 2025-12-17 | UBS | $11 | 189.5% upside | |
| 2025-12-17 | Morgan Stanley | $11 | 189.5% upside | |
| 2025-02-28 | Leerink Partners | $6 | 57.9% upside | |
| 2024-09-04 | NeedhamGil Blum | $11 | 189.5% upside | |
| 2024-09-03 | KeyBancScott Schoenhaus | $12 | 215.8% upside | |
| 2024-09-03 | JefferiesDennis Ding | $6 | 57.9% upside | |
| 2024-06-26 | KeyBancScott Schoenhaus | $16 | 321.1% upside | |